Co-Diagnostics, Inc.
CODX
$0.40
-$0.06-12.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.73M | -7.53M | -11.03M | -9.70M | -7.60M |
| Total Depreciation and Amortization | 291.40K | 280.40K | 357.10K | 351.20K | 338.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 309.60K | -174.60K | 713.90K | 879.50K | 1.75M |
| Change in Net Operating Assets | -1.16M | -1.32M | 1.73M | 1.24M | 304.60K |
| Cash from Operations | -8.29M | -8.75M | -8.23M | -7.23M | -5.20M |
| Capital Expenditure | -401.10K | -91.90K | -73.00K | -174.40K | -98.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.47M | 7.45M | 339.00K | 4.34M | -3.94M |
| Cash from Investing | 17.07M | 7.36M | 266.00K | 4.17M | -4.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 429.00K | 354.70K | 103.90K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 429.00K | 354.70K | 103.90K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.21M | -1.03M | -7.86M | -3.06M | -9.24M |